Cargando…

Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome—A Randomized Controlled Trial

Sympathetic nervous system (SNS) activity is increased in polycystic ovary syndrome (PCOS). Moxonidine is a centrally acting sympatholytic drug with known beneficial effects on hypertension, insulin sensitivity, dyslipidemia and inflammation. In this double-blind placebo controlled randomized clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shorakae, Soulmaz, Lambert, Elisabeth A., Jona, Eveline, Ika Sari, Carolina, de Courten, Barbora, Dixon, John B., Lambert, Gavin W., Teede, Helena J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210452/ https://www.ncbi.nlm.nih.gov/pubmed/30410448 http://dx.doi.org/10.3389/fphys.2018.01486

Ejemplares similares

Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial
por: Jewson, Jacob, et al.
Publicado: (2020)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
por: Mesinovic, Jakub, et al.
Publicado: (2020)

Effects of moxonidine on sympathetic nervous system activity: An update on metabolism, cardio, and other target-organ protection
por: Karlafti, Eleni F., et al.
Publicado: (2013)

Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome
por: Scott, David, et al.
Publicado: (2016)

Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity
por: Stener-Victorin, Elisabet, et al.
Publicado: (2005)

Change in Sympathetic Nerve Firing Pattern Associated with Dietary Weight Loss in the Metabolic Syndrome
por: Lambert, Elisabeth, et al.
Publicado: (2011)

A2 Noradrenergic Lesions Prevent Renal Sympathoinhibition Induced by Hypernatremia in Rats
por: Pedrino, Gustavo Rodrigues, et al.
Publicado: (2012)

SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020)

Sympathetic nervous system activity in health and disease—advances with microneurographic recordings
por: Lambert, Elisabeth
Publicado: (2012)

The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial
por: Hiam, Danielle, et al.
Publicado: (2019)

Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine
por: Palkovits, Miklós, et al.
Publicado: (2013)

Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects
por: Straznicky, Nora E., et al.
Publicado: (2010)

Physical activity and mental health in women with Polycystic Ovary Syndrome
por: Banting, Lauren K, et al.
Publicado: (2014)

Expression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (PCOS) state
por: Burchall, Genia F., et al.
Publicado: (2019)

Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
por: Hutchison, Samantha K., et al.
Publicado: (2008)

Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake
por: Baqar, Sara, et al.
Publicado: (2019)

Advances in Sympathetic Nerve Recording in Humans
por: Lambert, Elisabeth, et al.
Publicado: (2012)

Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss
por: Straznicky, Nora E., et al.
Publicado: (2016)

Mental Health and Physical Activity in Women with Polycystic Ovary Syndrome: A Brief Review
por: Conte, Francesca, et al.
Publicado: (2014)

Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients
por: Kaye, David M., et al.
Publicado: (2022)

Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome
por: Lambert, Elisabeth, et al.
Publicado: (2014)

Development of Hydrophilic Interaction Liquid Chromatography Method for the Analysis of Moxonidine and Its Impurities
por: Filipic, Slavica, et al.
Publicado: (2016)

Clinical management of pregnancy in women with polycystic ovary syndrome: An expert opinion
por: Bahri Khomami, Mahnaz, et al.
Publicado: (2022)

Neck Circumference Is Associated with Muscle Sympathetic Nerve Activity in Overweight and Obese Men but Not Women
por: Straznicky, Nora E., et al.
Publicado: (2017)

Mouse Anaphylactic Hypotension Is Characterized by Initial Baroreflex Independent Renal Sympathoinhibition Followed by Sustained Renal Sympathoexcitation
por: Zhang, Tao, et al.
Publicado: (2017)

“The whole package deal”: experiences of overweight/obese women living with polycystic ovary syndrome
por: Ee, Carolyn, et al.
Publicado: (2020)

A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
por: Seyit, Murat, et al.
Publicado: (2015)

Adolescent polycystic ovary syndrome according to the international evidence-based guideline
por: Peña, Alexia S., et al.
Publicado: (2020)

Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity
por: Neven, Adriana C. H., et al.
Publicado: (2023)

Polycystic Ovary Syndrome Presents Higher Sympathetic Cardiac Autonomic Modulation that is not altered by Strength Training
por: RIBEIRO, VICTOR B., et al.
Publicado: (2016)

Longitudinal Weight Gain and Lifestyle Factors in Women With and Without Polycystic Ovary Syndrome
por: Awoke, Mamaru Ayenew, et al.
Publicado: (2021)

SAT-015 Incidence and Predictors of Hypertension in a Cohort of Australian Women with and Without Polycystic Ovary Syndrome
por: Kakoly, Nadira Sultana, et al.
Publicado: (2020)

Effect of vitamin D supplementation on inflammation: protocol for a systematic review
por: Mousa, Aya, et al.
Publicado: (2016)

The Association of a Mediterranean-Style Diet Pattern with Polycystic Ovary Syndrome Status in a Community Cohort Study
por: Moran, Lisa J., et al.
Publicado: (2015)

Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial
por: de Courten, Barbora, et al.
Publicado: (2015)

The Effect of Exercise on Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Breyley-Smith, Annabelle, et al.
Publicado: (2022)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome(†)(‡)
por: Teede, Helena J, et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome
por: Scott, David, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uioog9rrks9bt41smbnkbf4r1e